From Assumptions to Co-Creation: The Patient Voice in Drug Development скачать в хорошем качестве

From Assumptions to Co-Creation: The Patient Voice in Drug Development

Transforming Drug Development Through Patient Partnership Rebecca Vermeulen, VP of Global Patient Networks at Genentech/Roche, shares how they built a patient partnership program that's transformed drug development over the past decade. Key Topics Covered: The journey from patient-focused to patient-partnered drug development Breaking down the assumption barrier: "You can't assume you know what somebody needs until you've lived in their shoes" Building a global patient partnership team within product development Integrating patient voices from early development through market access Real impact: SMA community collaboration creating patient-centered endpoints that became part of product labeling Myth-busting: Early patient engagement accelerates rather than slows development Cross-industry collaboration through Patient Focused Medicines Development (PFMD) The Transformation Story: 10 years ago, Roche recognized a critical gap: they were patient-focused but didn't have patients at the table making decisions. The solution was creating dedicated patient partnership leaders who build lasting relationships with patient communities and integrate their perspectives throughout the development process. Real Impact Example: Working with the SMA community led to implementable protocols, patient-centered endpoints showing babies could sit up, universal newborn screening, and endpoints that became part of the product label - demonstrating treatment impact in ways that matter most to families. Industry Evolution: Rebecca emphasizes that improving patient care requires collaboration across the entire healthcare ecosystem - industry, regulators, patient communities, health systems, and governments working together through organizations like PFMD. Subscribe for more patient-centered healthcare insights. #PatientPartnership #PatientEngagement #RebeccaVermeulen #Genentech #Roche #PatientCentricDevelopment #DrugDevelopment #RareDisease #SMA #PFMD #PatientVoice #HealthcareInnovation #ClinicalDevelopment #TherapeuticDevelopment #PatientExperience